Vaccine Panel Recommends RSV Shots for Infants Amid FDA Approvals
TL;DR Summary
The CDC's vaccine advisory panel recommended a new monoclonal antibody shot for infants under 8 months to protect against RSV, with final approval pending CDC director and HHS Secretary sign-off. The panel also discussed updates to childhood immunization schedules and reviewed COVID-19 vaccine data, emphasizing ongoing safety monitoring and the impact of vaccines on public health.
- CDC vaccine advisory panel to study child immunization schedule, recommends RSV shot for babies ABC News - Breaking News, Latest News and Videos
- In surprise move, RFK Jr.'s vaccine committee votes to recommend RSV shot for infants USA Today
- RFK Jr.'s vaccine advisors recommend RSV antibodies for infants Axios
- RFK Jr.’s Advisers Back Merck’s RSV Shot for Newborns Bloomberg.com
- FDA Approves Merck’s Enflonsia for RSV Prevention, Competing with Sanofi and AstraZeneca’s Beyfortus geneonline.com
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
4 min
vs 5 min read
Condensed
93%
830 → 56 words
Want the full story? Read the original article
Read on ABC News - Breaking News, Latest News and Videos